Fig. 3From: mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysisForest plot showing the relative risk of biopsy-proven acute rejection at 6 months, 1 year, 2 years and at the end of the follow-up periodBack to article page